衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體

Polyclonal Antibody to Fibulin 1 (FBLN1)

  • 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體產(chǎn)品包裝(模擬)
  • 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體產(chǎn)品包裝(模擬)
  • 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體IHC圖
  • PAC472Mu01.jpgFigure. Western Blot; Sample: Recombinant FBLN1, Mouse.
  • 衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體Western Blot; Sample: Lane1: Mouse Serum; Lane2: Mouse Heart lysate; Lane3: Mouse Placenta lysate
    Primary Ab: 0.3μg/ml Rabbit Anti-Mouse FBLN1 Antibody
    Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對FBLN1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗中能識別FBLN1。

用法

Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號適用物種:Mus musculus (Mouse,小鼠)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPC472Mu01衰老關(guān)鍵蛋白1(FBLN1)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAC472Mu01衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體WB; IHC; ICC; IP.
LAC472Mu71衰老關(guān)鍵蛋白1(FBLN1)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAC472Mu22衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體WB; IHC; ICC; IP.
MAC472Mu21衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體IHC; ICC/IF
LAC472Mu72衰老關(guān)鍵蛋白1(FBLN1)單克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
SEC472Mu衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒(酶聯(lián)免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMC472Mu衰老關(guān)鍵蛋白1(FBLN1)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
PSC472Mu01衰老關(guān)鍵蛋白1(FBLN1)抗體對ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSC472Mu01衰老關(guān)鍵蛋白1(FBLN1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志參考文獻(xiàn)
Clin Exp Metastasis.Augmented expression of urokinase plasminogen activator and extracellular matrix proteins associates with multiple myeloma progression[Pubmed:24807734]
Proteomics Clinical ApplicationsComparative mass spectrometric and immunoassay‐based proteome analysis in serum of Duchenne muscular dystrophy patients[Pubmed:26680509]
PROTEOMICS?-?Clinical?ApplicationsComparative mass spectrometric and immunoassay-based?proteome?analysis?in?serum?ofDuchenne muscular dystrophy?patients.[pubmed:26680509]
ENVIRONMENTAL RESEARCHExploration of identifying novel serum biomarkers for malignant mesothelioma using iTRAQ combined with 2D-LC-MS/MS[Pubmed: 33197421]